This invention relates to a device for fastening and anchoring heart valve prostheses which is essentially formed of wire-shaped interconnected elements. The aim of the invention is to be able to be implant, in a minimally invasive manner, a device of this type via the aorta by compressing the device to make it smaller, and by extending the same at the site of implantation, whereby ensuring a secure retention and a secure sealing with regard to the aorta wall. To this end, the invention provides that for fastening and supporting a cardiac valve prosthesis, three identical pairs of arched elements are interconnected, with a configuration that is offset by 120°, by means of solid body articulations. These solid body articulations carry out the function of pivot bearings.

Patent
   RE45130
Priority
Feb 28 2000
Filed
Jun 26 2008
Issued
Sep 09 2014
Expiry
Feb 28 2021
Assg.orig
Entity
Small
4
435
all paid
1. A device for fastening and anchoring a heart valve prosthesis, the device consisting of three identical sections, each section being coupled to adjacent sections on each side of said section by an elongated supporting ridge extending in a direction generally parallel to a longitudinal axis of the device, each section having a first arched element arched in a first direction, a second arched element arched in the first direction, and a third arched element arched in a second direction opposite from the first direction, the second and third arched elements being coupled to the first arched element at first points to define between the first and second arched elements a first space, each section further comprising a fourth arched element arched in the second direction and having ends coupled to the first arched element of said section and a the first arched element of an adjacent section at second points distinct from the first points to define between the fourth arched element and the adjacent first arched elements a second space.
0. 12. A medical device, in combination with a heart valve prosthesis, the medical device consisting of three substantially identical sections, each section being coupled to adjacent sections on each side of the section, the medical device being implantable in a body via a catheter and including a collapsed mode and an expanded mode, each section including:
a first arched element arched in a first direction, the first arched element disposed at a distal end of the device;
a second arched element arched in the first direction, the second arched element disposed at the distal end of the device and connected to the first arched element at first points; and
a fourth arched element arched in a second direction opposite from the first direction and having ends coupled to the first arched element of said section and the first arched element of an adjacent section at second points distinct from the first points to define between the fourth arched element and the adjacent first arched elements a space;
wherein the heart valve prosthesis is fixedly attached to the first, second, and fourth arched elements of each of the three sections and remains fixedly attached to function as a heart valve after removal of the catheter from the body, the heart valve prosthesis repeatedly opening and closing to allow and prevent blood flow, respectively, through the medical device.
2. A device for supporting a heart valve prosthesis, the device consisting essentially of three substantially identical elements, each element being coupled to adjacent elements on each side of said element by an elongated supporting member extending in a direction generally parallel to a longitudinal axis of the device, each element including a first arched member coupled to, and extending in a first direction generally away from said first arched member's respective supporting members, and a second arched member coupled to the first arched member at points different from the first arched member's coupling to its respective supporting members, the second arched member extending generally in a second direction opposite from the first direction, wherein each element further includes a third arched member coupled to the first arched member at substantially the same points as the second arched member is coupled to the first arched member, the third arched member extending generally in the first direction, each element further including a pair of fourth arched members, each of said fourth arched members extending alongside, and conforming generally to, the curvature of a portion of the first arched member, each of the fourth arched members being coupled to a first arched member intermediate opposite ends of said first arched member and extending from said coupling to said first arched member generally in said second direction toward a respective supporting member.
0. 27. A medical device, in combination with a heart valve prosthesis, the medical device consisting of three substantially identical sections, each section being coupled to adjacent sections on each side of the section, the medical device being implantable in a body via a catheter and having a first, compressed mode and a second, expanded mode, each section including:
a first arched element arched in a first direction, the first arched element disposed at a distal end of the device;
a third arched element arched in a second direction opposite from the first direction, the first and third arched elements connected to each other at a first point, wherein between an apex of the first arched element and an apex of the third arched element there is a space; and
a fourth arched element arched in a direction opposite from the first direction and having a first end coupled to the first arched element of said section at a second point and a second end coupled to the first arched element of an adjacent section at a third point, the second point and the third point being distinct from the first point to define between the fourth arched element and the adjacent first arched elements a space;
wherein the heart valve prosthesis is fixedly attached to the first and fourth arched elements of each of the three sections and remains fixedly attached to function as a heart valve after removal of the catheter from the body, the heart valve prosthesis repeatedly opening and closing to allow and prevent blood flow, respectively, through the medical device.
0. 29. A medical device, in combination with a heart valve prosthesis fixedly attached to the medical device, the medical device consisting of three substantially identical sections, each section being coupled to adjacent sections on each side of the section, the medical device being implantable in a body via a catheter and having a first, compressed mode and a second, expanded mode, each section including:
a first arched element arched in a first direction, the first arched element connected to a supporting ridge and disposed on a first, distal end of the supporting ridge;
a third arched element arched in a second direction opposite from the first direction, the first and third arched elements connected to each other at a first point, wherein between an apex of the first arched element and an apex of the third arched element there is a space; and
a fourth arched element arched in a direction opposite from the first direction and having ends coupled to the first arched element of said section and the first arched element of an adjacent section, wherein a curvature of the fourth arched element is different from a curvature of the third arched element; and
a plurality of undulating transverse ridges connected to the supporting ridge and disposed on a second, proximal end of the supporting ridge opposite the first, distal end, such that the supporting ridge is disposed proximal to the first arched element and distal to the plurality of undulating transverse ridges, the plurality of undulating transverse ridges including at least two sets of undulating transverse ridges, each set of undulating transverse ridges extending around a circumference of the medical device;
wherein the heart valve prosthesis remains fixedly attached to the medical device to function as a heart valve after removal of the catheter from the body, the heart valve prosthesis repeatedly opening and closing to allow and prevent blood flow, respectively, through the medical device.
3. The device of claim 2 wherein each fourth arched member extends to a point adjacent a respective supporting member, turns, and extends generally in the first direction, conforming generally to the curvature of a portion of a first arched member of an adjacent element on one side of said element.
4. The device of claim 3 wherein each element further includes transversal members extending between its respective supporting members.
5. The device of claim 4 wherein at least some of said transversal members include tips to facilitate anchoring of said device into tissue of a vessel or the heart of a wearer of the device.
6. The device of claim 4 constructed from memory metal.
7. The device of claim 3 constructed from memory metal.
8. The device of claim 2 wherein each element further includes transversal members extending between its respective supporting members.
9. The device of claim 8 wherein at least some of said transversal members include tips to facilitate anchoring of said device into tissue of a vessel or the heart of a wearer of the device.
10. The device of claim 8 constructed from memory metal.
11. The device of claim 2 constructed from memory metal.
0. 13. The medical device, in combination with the heart valve prosthesis of claim 12, each section further including:
a third arched element arched in the second direction, the third arched element connected to the first and second arched elements at the first points.
0. 14. The medical device, in combination with the heart valve prosthesis of claim 13, wherein each section further includes an eyelet element disposed at a proximal end of the device opposite the distal end.
0. 15. The medical device, in combination with the heart valve prosthesis of claim 12, wherein each of the three fourth arched elements conforms generally to a curvature of a portion of the first arched element of the first section and the curvature of a portion of the first arched element of the adjacent section.
0. 16. The medical device, in combination with the heart valve prosthesis of claim 12, wherein at least one of the second points pivots when a pressure force is exerted upon one of the first or fourth arched elements.
0. 17. The medical device, in combination with the heart valve prosthesis of claim 12, wherein the device is configured to be implanted within an aorta.
0. 18. The medical device, in combination with the heart valve prosthesis of claim 12, wherein each section is coupled to the adjacent sections by a supporting ridge, each section further including transversal members extending between adjacent elongated supporting ridges.
0. 19. The medical device, in combination with the heart valve prosthesis of claim 18, wherein at least some of said transversal members include tips to facilitate anchoring of said device into tissue of a vessel or a heart of a patient.
0. 20. The medical device, in combination with the heart valve prosthesis of claim 18, wherein the transversal members have a saw-tooth shape.
0. 21. The medical device, in combination with the heart valve prosthesis of claim 18, wherein the transversal members have a rhombic shape.
0. 22. The medical device, in combination with the heart valve prosthesis of claim 12, wherein the heart valve prosthesis is a biological heart valve prosthesis.
0. 23. The medical device, in combination with the heart valve prosthesis of claim 12, wherein the heart valve prosthesis is an artificial heart valve prosthesis.
0. 24. The medical device, in combination with the heart valve prosthesis of claim 12, wherein the three sections are spaced substantially 120 degrees apart.
0. 25. The medical device, in combination with the heart valve prosthesis of claim 12, wherein the device is constructed from memory metal.
0. 26. The medical device, in combination with the heart valve prosthesis of claim 12, wherein the device is balloon expandable.
0. 28. The medical device, in combination with the heart valve prosthesis of claim 27, wherein the first point is a pivot point about which the third arched element can move.
0. 30. The medical device, in combination with a heart valve prosthesis of claim 29, further including an eyelet element connected to at least one of the plurality of undulating transverse ridges.
0. 31. The medical device, in combination with a heart valve prosthesis of claim 29, wherein the plurality of undulating transverse ridges form a supporting body configured to engage a portion of a vessel wall when the medical device is in the expanded mode at a deployed state.
0. 32. The medical device, in combination with a heart valve prosthesis of claim 29, wherein the device is configured to be implanted within an aorta.
0. 33. The medical device, in combination with a heart valve prosthesis of claim 29, wherein at least one of the plurality of undulating transverse ridges includes tips to facilitate anchoring of the device into tissue of a vessel or a heart of a patient.
0. 34. The medical device, in combination with a heart valve prosthesis of claim 29, wherein the plurality of undulating transverse ridges have a saw-tooth shape.
0. 35. The medical device, in combination with a heart valve prosthesis of claim 29, wherein the plurality of undulating transverse ridges have a rhombic shape.
0. 36. The medical device, in combination with a heart valve prosthesis of claim 29, wherein the heart valve prosthesis is a biological heart valve prosthesis.
0. 37. The medical device, in combination with a heart valve prosthesis of claim 29, wherein the heart valve prosthesis is an artificial heart valve prosthesis.
0. 38. The medical device, in combination with a heart valve prosthesis of claim 29, wherein the three sections are spaced substantially 120 degrees apart.
0. 39. The medical device, in combination with a heart valve prosthesis of claim 29, wherein the device is constructed from memory metal.
0. 40. The medical device, in combination with a heart valve prosthesis of claim 29, wherein the device is balloon expandable.

This application is a U.S. national counterpart application of international application serial no. PCT/DE01/00837 filed Feb. 28, 2001, which claims priority to German application serial No. 100 10 074.0 filed Feb. 28, 2000.

The invention relates to a device for fastening and anchoring cardiac valve prostheses which is essentially formed of wire-shaped interconnected elements. In the folded up state it is allowed to be introduced through the aorta in a minimally invasive manner, and be anchored in the aorta wall after being deployed such that the implanted and secured heart valve prosthesis is allowed to adopt the function of the endogenous heart valve.

Heretofore, it did not succeed in a satisfactory extent to suggest a solution wherein both a secure sealing against the aorta wall and a secure retention can be ensured. On that occasion, such a device or such an anchoring support (stent) must be able to be folded up small enough in order to be stretched then at the site of implantation. With the known solutions a satisfactory enlargement will not be achieved with the appropriate tension force which is allowed to ensure such a retention. Proposals in which a form storage metal (memory metal) is to be used as well do not meet the requirements although an expansion takes place with these materials when a transition temperature has been reached and exceeded, respectively.

The solution as described in U.S. Pat. No. 5,411,552 cannot meet the requirements as well since a relatively instable object is to be used.

Another problem which is solved in an unsatisfactory manner so far is the secure attachment of an artificial or biological heart valve prosthesis. As a rule, the prostheses are lavishly sewn on to a stent. This is time-consuming and has to be carried out with great care in order to avoid damages.

Since the implanted heart valve prostheses have to be able to function over long periods the constructional design plays an essential role as well since damages and leakages can occur after the implantation otherwise which can result in life threatening states of the patient.

Hence, it is an object of the invention to suggest a device for fastening and anchoring heart valve prostheses which can be folded up small enough, and deployed at the site of implantation for a minimally invasive implantation through the aorta wherein a secure retention and a secure sealing with respect to the aorta wall are ensured.

According to the invention this object is solved with a device according to claim 1.

Advantageous embodiments and improvements of the invention can be achieved with the features mentioned in the subclaims.

Three identical pairs of arched elements each are substantial elements of the solution according to the invention which are interconnected in a configuration that is offset by 120°. The two arched elements of one pair are bent opposite to each other in a curved manner and connected by means of solid articulations. The solid articulations simultaneously meet the function of pivot bearings about which the arched elements of one pair can be swivelled similarly as with a seesaw. If a pressure force is exerted upon one of the arched elements, e.g. through the peristaltic action of the aorta, this arched element will be swivelled according to the same direction about the axis of rotation on the solid articulation. Simultaneously, the respective other arched element of the pair will be swivelled opposite thereto. Therefore, one of the two arched elements of the pair is then already pressed against the aorta wall increasing the sealing and the retention.

It is favourable to dimension the arched elements of a pair such that as far as possible the same lever relations are met with respect to the solid articulations forming the pivot bearings, thus rocker arms with an identical length or at least with approximately the same length will be formed.

The relative great distances of the solid articulations predetermined by the configuration of 120° of the pairs of arched elements, and the large surface areas covered by the arched elements as well are also advantageous wherein the distal arched elements do not only serve for fastening the heart valve prosthesis but also adopt a supporting function.

The mentioned advantages can still be improved by means of another curved arched element which is arranged in the distal direction.

On that occasion, the second distal arched element in its distal area is designed in a curved manner approximately like the first distal arched element. Partly, these two arched elements are designed and shaped such that they pass adjacent to each other, and gaps are formed between them. They are allowed to be interconnected at the same place at which the solid articulations are also arranged as a connection toward the arched element curved in the proximal direction. Hence, the formed gaps are open in the distal direction, and portions of the heart valve prosthesis are allowed to be introduced into the gaps and be supported.

At least one portion of a distal arched element is proximally retracted and guided up to a turning point in which adjacent arched elements are collected. With two distally arranged arched elements this applies to the respective distally outer arched element.

For stiffening and as a further possibility of fastening the heart valve prosthesis it is allowed to use an angular curved arched element being proximally retracted as well, the curved portions of which are located between the respective adjacent arched elements and are formed partly following the respective curvature. These arched elements with the distal ends thereof are secured to the one distally outer arched element or the respective distally outer arched element. Herein, the attachment also forms a respective solid articulation. These should still be located in a distance to the other solid articulations connecting one pair.

With a device being implanted and stretched over the pockets of a heart valve prosthesis then can be pushed in, held and supported there.

The construction of the arched element of the device according to the invention supports a heart valve prosthesis in a large-surface manner, and therefore with care. Additionally, it is allowed to be fastened with a substantially lower amount, for example by sewing.

The constructional solution enables a secure retention and the required sealing on the aorta wall, and with respect thereto, respectively. Pressing against the heart valve prosthesis from the inside by means of the arched element is advantageous for the sealing and for a reduced load of the heart valve prosthesis.

The device according to the invention can be implanted by means of a balloon catheter and can be deployed at the site of implatation. Advantageously, for the device is used a form storage metal as well having a suitable transition temperature by means of which an extension can be additionally achieved. For this, an alloy containing nickel and titanium can be employed which is available under the designation of Nitinol.

Moreover, the portion of the device supporting and holding the heart valve prosthesis can be implanted separately to a supporting body which is still referred to hereinafter with the description of an embodiment without reducing the advantageous properties. The implantation of this portion substantially consisting of the three segments having the heart valve prosthesis attached thereto then can operatively take place in a conventional form.

In the text that follows, the invention will be explained in more detail according to an embodiment in which

FIG. 1 shows a developed view of an embodiment of a device according to the invention.

In FIG. 1 is shown a developed view of an embodiment of a device according to the invention. The device is radially symmetrically designed wherein three identical portions are used in a configuration of 120°.

Each portion uses an arched element construction as a carrier and for fastening an artificial or biological heart valve prosthesis.

With this embodiment two arched elements 4 and 5 are used which are distally arranged outside wherein the outer arched element 5 could be abandoned as the case may be.

The arched element 4 bent into a curved manner is connected to an arched element 3 which is bent in the opposite direction. The two sided connections represent solid articulations 7 which simultaneously adopt pivot functions for the two arched elements 3 and 4 representing levers as it is already described in the general part of the description.

The second arched element 3 which is outwardly bent and distally arranged increases the stability and offers an additional supporting and fastening possibility for the heart valve prosthesis. On that occasion, the two distally outer arched elements 4 and 5 are interconnected as well, wherein this connection is allowed to occur at the same place at which the solid articulations 7 are also arranged.

There are gaps between the two arched elements 4 and 5 which are open from the distal direction into which the portions of the heart valve prosthesis can be introduced and fixed there.

The arched element 5 being the outer one here is further inwardly pulled in the proximal direction, and is connected with its end to a respective supporting ridge 8. In this embodiment, the supporting ridges 8 are aligned in parallel to the longitudinal axis of the device, and together with saw tooth shaped, rhombic or meander shaped transversal ridges they form a supporting body which in the deployed state closely fits on the aorta wall. For interlocking, additional tips 9 can be present and designed, respectively, on the supporting ridges 8, and/or the transversal ridges which interlock in the aorta wall.

The configuration and length of the supporting ridges 8, and the respective great distance toward the heart valve prosthesis fastened in the area of the arched elements 3, 4 and 5 enable positioning the heart valve prosthesis without locking and covering the coronary vessels, respectively.

With the embodiment as shown herein, additional arched elements 2 being proximally pulled in are present between the individual segments used in a configuration of 120° which are connected to the distally outer arched elements 5. Herein, the connections are solid articulations 6 as well, however, which should be arranged in a distance toward the solid articulations 7 as far as possible. Thus, two levers per segment can be used, and forces twice as large can be realized with such a double-reflected structure in order to fix the device.

In the deployed implanted state the portions of the heart valve prosthesis can be mutually introduced in turn between the portions 1 of the arched elements 5 and the arched elements 2, thus being supported and fixed thereto.

The number of the arched elements used can still be increased, however, to improve the retention and to further decrease the load of the heart valve prosthesis.

Ferrari, Markus, Weber, Carsten, Figulla, Hans-Reiner, Peschel, Thomas, Damm, Christoph

Patent Priority Assignee Title
10285809, Mar 06 2015 Boston Scientific Scimed, Inc TAVI anchoring assist device
12121461, Mar 20 2015 JENAVALVE TECHNOLOGY, INC Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath
12171658, Nov 09 2022 JenaValve Technology, Inc. Catheter system for sequential deployment of an expandable implant
9381103, Oct 06 2014 ABBOTT CARDIOVASCULAR SYSTEMS INC Stent with elongating struts
Patent Priority Assignee Title
3755823,
4106129, Jan 09 1976 Baxter International Inc Supported bioprosthetic heart valve with compliant orifice ring
4922905, May 28 1987 Boston Scientific Corporation Dilatation catheter
4994077, Apr 21 1989 Artificial heart valve for implantation in a blood vessel
5002566, Feb 17 1989 Edwards Lifesciences Corporation Calcification mitigation of bioprosthetic implants
5061277, Aug 06 1986 Edwards Lifesciences Corporation Flexible cardiac valvular support prosthesis
5094661, Apr 01 1988 BOARD OF THE REGENTS ACTING FOR AND ON BEHALF OF THE UNIVERSITY OF MICHIGAN, THE, ANN ARBOR, MI , A CORP OF MI Calcification-resistant materials and methods of making same through use of trivalent aluminum
5104407, Feb 13 1989 Edwards Lifesciences Corporation Selectively flexible annuloplasty ring
5163953, Feb 10 1992 Toroidal artificial heart valve stent
5197979, Sep 07 1990 Edwards Lifesciences Corporation Stentless heart valve and holder
5234456, Feb 08 1990 SciMed Life Systems, INC; Boston Scientific Scimed, Inc Hydrophilic stent
5279612, Jun 09 1989 Medtronic, Inc. Dynamic fixation of porcine aortic valves
5332402, May 12 1992 Percutaneously-inserted cardiac valve
5336258, Sep 07 1990 Edwards Lifesciences Corporation Stentless heart valve and holder
5342348, Dec 04 1992 Method and device for treating and enlarging body lumens
5352240, May 31 1989 CRYOLIFE, INC Human heart valve replacement with porcine pulmonary valve
5368608, Apr 01 1988 UNIVERSITY OF MICHIGAN, THE BOARD OF REGENTS ACTING FOR AND ON BEHALF OF THE Calcification-resistant materials and methods of making same through use of multivalent cations
5397351, May 13 1991 Prosthetic valve for percutaneous insertion
5411552, May 18 1990 Edwards Lifesciences AG Valve prothesis for implantation in the body and a catheter for implanting such valve prothesis
5456713, Oct 25 1991 Cook Incorporated Expandable transluminal graft prosthesis for repairs of aneurysm and method for implanting
5476508, May 26 1994 TFX Medical Stent with mutually interlocking filaments
5509930, Dec 17 1993 Medtronic, Inc Stentless heart valve
5549666, Sep 02 1994 Edwards Lifesciences Corporation Natural tissue valve prostheses having variably complaint leaflets
5595571, Apr 18 1994 Hancock Jaffe Laboratories Biological material pre-fixation treatment
5613982, Mar 14 1994 HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS SUCCESSOR AGENT Method of preparing transplant tissue to reduce immunogenicity upon implantation
5632778, Mar 14 1994 HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS SUCCESSOR AGENT Treated tissue for implantation and methods of preparation
5674298, Oct 21 1994 The Board of Regents of the University of Michigan Calcification-resistant bioprosthetic tissue and methods of making same
5679112, Apr 01 1988 University of Michigan, The Board of Regents Acting For and on Behalf of Calcification-resistant materials and methods of making same through use of multivalent cations
5683451, Jun 08 1994 Medtronic Ave, Inc Apparatus and methods for deployment release of intraluminal prostheses
5697972, Jul 13 1994 Korea Institute of Science and Technology Bioprosthetic heart valves having high calcification resistance
5713953, May 24 1991 Sorin Biomedica Cardio S.p.A. Cardiac valve prosthesis particularly for replacement of the aortic valve
5746775, Apr 01 1988 UNIVERSITY OF MICHIGAN, THE BOARD OF REGENTS ACTING FOR AND ON BEHALF OF THE Method of making calcification-resistant bioprosthetic tissue
5755777, Oct 25 1991 Cook Incorporated Expandable transluminal graft prosthesis for repair of aneurysm
5824041, Jun 08 1994 Medtronic Ave, Inc Apparatus and methods for placement and repositioning of intraluminal prostheses
5824080, Sep 04 1996 General Hospital Corporation, The Photochemistry for the preparation of biologic grafts--allografts and xenografts
5840081, May 18 1990 Edwards Lifesciences AG System and method for implanting cardiac valves
5841382, Mar 19 1997 AVAGO TECHNOLOGIES GENERAL IP SINGAPORE PTE LTD Fast testing of D/A converters
5843181, May 16 1995 Hancock Jaffe Laboratories Biological material pre-fixation treatment
5853419, Mar 17 1997 NFOCUS NEUROMEDICAL, INC Stent
5855601, Jun 21 1996 The Trustees of Columbia University in the City of New York Artificial heart valve and method and device for implanting the same
5876434, Jul 13 1997 Litana Ltd. Implantable medical devices of shape memory alloy
5880242, Mar 04 1996 Edwards Lifesciences Corporation Nonpolymeric epoxy compounds for cross linking biological tissue and bioprosthetic grafts prepared thereby
5899936, Mar 14 1994 HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS SUCCESSOR AGENT Treated tissue for implantation and methods of preparation
5928281, Mar 27 1997 Edwards Lifesciences Corporation Tissue heart valves
5935163, Mar 31 1998 GABBAY, SHLOMO Natural tissue heart valve prosthesis
5964798, Dec 16 1997 NFOCUS LLC; Covidien LP Stent having high radial strength
6001126, Dec 24 1997 Edwards Lifesciences Corporation Stentless bioprosthetic heart valve with coronary protuberances and related methods for surgical repair of defective heart valves
6077297, Jan 12 1998 C. R. Bard, Inc. Non-migrating vascular prosthesis and minimally invasive placement system therefor
6093530, Feb 06 1998 CORCYM S R L Non-calcific biomaterial by glutaraldehyde followed by oxidative fixation
6102944, Mar 27 1997 Edwards Lifesciences Corporation Methods of tissue heart valve assembly
6117169, Jun 24 1998 CORCYM S R L Living hinge attachment of leaflet to a valve body
6126685, Jun 08 1994 Medtronic Ave, Inc Apparatus and methods for placement and repositioning of intraluminal prostheses
6146417, Aug 22 1996 X TECHNOLOGIES INC Tubular stent
6168614, May 18 1990 Edwards Lifesciences AG Valve prosthesis for implantation in the body
6177514, Apr 09 1999 Sulzer Carbomedics Inc. Blocked functional reagants for cross-linking biological tissues
6183481, Sep 22 1999 LIFEPORT SCIENCES LLC Delivery system for self-expanding stents and grafts
6190405, May 28 1997 GFE Corporation for Research and Development Unlimited Flexible expandable vascular support
6200336, Jun 02 1998 Cook Medical Technologies LLC Multiple-sided intraluminal medical device
6214055, Oct 30 1998 Mures Cardiovascular Research, Inc.; MURES CARDIOVASCULAR RESEARCH, INC Method and kit for rapid preparation of autologous tissue medical devices
6231602, Apr 16 1999 Edwards Lifesciences Corporation Aortic annuloplasty ring
6245102, May 07 1997 Vascular Concepts Holdings Limited Stent, stent graft and stent valve
6254564, Sep 10 1998 JENAVALVE TECHNOLOGY, INC ; JVT RESEARCH & DEVELOPMENT CORPORATION Left ventricular conduit with blood vessel graft
6254636, Jun 26 1998 St. Jude Medical, Inc. Single suture biological tissue aortic stentless valve
6283995, Apr 15 1999 CORCYM S R L Heart valve leaflet with scalloped free margin
6287338, Mar 10 1999 CORCYM S R L Pre-stressing devices incorporating materials subject to stress softening
6338740, Jan 26 1999 Edwards Lifesciences Corporation Flexible heart valve leaflets
6342070, Dec 24 1997 Edwards Lifesciences Corporation Stentless bioprosthetic heart valve with patent coronary protuberances and method of surgical use thereof
6344044, Feb 11 2000 Edwards Lifesciences Corp. Apparatus and methods for delivery of intraluminal prosthesis
6350278, Jun 08 1994 Medtronic AVE, Inc. Apparatus and methods for placement and repositioning of intraluminal prostheses
6379740, Dec 10 1997 SORIN BIOMEDICA CARDIO S P A Method for treating a prosthesis having an apertured structure and associated devices
6391538, Feb 09 2000 CHILDREN S HOSPITAL OF PHILADELPHIA, THE Stabilization of implantable bioprosthetic tissue
6425916, Feb 10 1999 Heartport, Inc Methods and devices for implanting cardiac valves
6454799, Apr 06 2000 Edwards Lifesciences Corporation Minimally-invasive heart valves and methods of use
6471723, Jan 10 2000 St. Jude Medical, Inc.; ST JUDE MEDICAL, INC Biocompatible prosthetic tissue
6478819, May 27 1999 CORCYM S R L Prosthetic heart valves with flexible post geometry
6508833, Jun 28 1998 Cook Medical Technologies LLC Multiple-sided intraluminal medical device
6509145, Sep 30 1998 Medtronic, Inc Process for reducing mineralization of tissue used in transplantation
6521179, Aug 11 1999 BIOMEDICAL DESIGN, INC Sterilization
6540782, Feb 02 2000 SNYDERS HEART VALVE LLC Artificial heart valve
6558417, Jun 26 1998 St. Jude Medical, Inc. Single suture biological tissue aortic stentless valve
6558418, Jan 26 1999 Edwards Lifesciences Corporation Flexible heart valve
6572642, Dec 10 1997 Sorin Biomedica Cardio S.p.A. Method for treating a prosthesis having an apertured structure and associated devices
6582462, May 18 1990 Edwards Lifesciences AG Valve prosthesis for implantation in the body and a catheter for implanting such valve prosthesis
6585766, Mar 27 1997 Edwards Lifesciences Corporation Cloth-covered stents for tissue heart valves
6613086, Jun 24 1998 CORCYM S R L Altering heart valve leaflet attachment geometry to influence the location and magnitude of maximum loaded stress on the leaflet
6626939, Dec 18 1997 SciMed Life Systems, INC; Boston Scientific Scimed, Inc Stent-graft with bioabsorbable structural support
6682559, Jan 27 2000 MEDTRONIC 3F THERAPEUTICS, INC Prosthetic heart valve
6730118, Oct 11 2001 EDWARDS LIFESCIENCES PVT, INC Implantable prosthetic valve
6736845, Jan 26 1999 Edwards Lifesciences Corporation Holder for flexible heart valve
6743252, Dec 18 1998 Cook Medical Technologies LLC Cannula stent
6767362, Apr 06 2000 Edwards Lifesciences Corporation Minimally-invasive heart valves and methods of use
6773455, Jun 24 1997 Advanced Cardiovascular Systems, Inc. Stent with reinforced struts and bimodal deployment
6790230, Apr 30 2001 MEDTECH DEVELOPMENT LLC Vascular implant
6808529, Feb 11 2000 Edwards Lifesciences Corporation Apparatus and methods for delivery of intraluminal prostheses
6821211, Sep 14 2001 GOLF TECH, LLC Sport swing analysis system
6821297, Feb 02 2000 SNYDERS HEART VALVE LLC Artificial heart valve, implantation instrument and method therefor
6824970, Feb 09 2000 The Children's Hospital of Philadelphia Stabilization of implantable bioprosthetic tissue
6830584, Nov 17 1999 Medtronic Corevalve LLC Device for replacing a cardiac valve by percutaneous route
6861211, Apr 27 1999 The Children's Hospital of Philadelphia Stabilization of implantable bioprosthetic devices
6872226, Jan 29 2001 3F THERAPEUTICS, INC Method of cutting material for use in implantable medical device
6881199, Sep 10 1998 JENAVALVE TECHNOLOGY, INC ; JVT RESEARCH & DEVELOPMENT CORPORATION Left ventricular conduit with blood vessel graft
6893460, Oct 11 2001 EDWARDS LIFESCIENCES PVT, INC Implantable prosthetic valve
6908481, Dec 31 1996 EDWARDS LIFESCIENCES PVT, INC Value prosthesis for implantation in body channels
6911043, Jan 27 2000 MEDTRONIC 3F THERAPEUTICS, INC Prosthetic heart value
6945997, Mar 27 1997 Edwards Lifesciences Corporation Heart valves and suture rings therefor
6974474, Jun 02 1998 Cook Medical Technologies LLC Multiple-sided intraluminal medical device
7014655, Dec 03 2001 FREY, RAINER Method for conserving biological prostheses, conserved biological prostheses and conserving solutions
7018406, Nov 17 1999 Medtronics CoreValve LLC Prosthetic valve for transluminal delivery
7037333, Jan 27 2000 MEDTRONIC 3F THERAPEUTICS, INC Prosthetic heart valve
7050276, Jun 13 2002 TDK Corporation GMR magnetic sensing element having an antiferromagnetic layer extending beyond the track width and method for making the same
7078163, Mar 30 2001 Medtronic, Inc. Process for reducing mineralization of tissue used in transplantation
7081132, May 16 2002 Cook Medical Technologies LLC Flexible barb for anchoring a prosthesis
7137184, Sep 20 2002 Edwards Lifesciences Corporation Continuous heart valve support frame and method of manufacture
7141064, May 08 2002 Edwards Lifesciences Corporation Compressed tissue for heart valve leaflets
7163556, Mar 21 2002 Providence Health System - Oregon Bioprosthesis and method for suturelessly making same
7189259, Nov 26 2002 Clemson University Research Foundation Tissue material and process for bioprosthesis
7198646, Feb 28 2000 JENAVALVE TECHNOLOGY, INC ; JVT RESEARCH & DEVELOPMENT CORPORATION Device for fastening and anchoring cardiac valve prostheses
7201772, Jul 08 2003 Medtronic Ventor Technologies Ltd Fluid flow prosthetic device
7238200, Jun 03 2005 Medtronic, Inc Apparatus and methods for making leaflets and valve prostheses including such leaflets
7252682, Jul 04 2001 MEDTRONIC CV LUXEMBOURG S A R L Kit enabling a prosthetic valve to be placed in a body enabling a prosthetic valve to be put into place in a duct in the body
7267686, Oct 21 1999 Boston Scientific Scimed, Inc Implantable prosthetic valve
7318278, Sep 20 2002 Edwards Lifesciences Corporation Method of manufacture of a heart valve support frame
7318998, Apr 11 1997 HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS SUCCESSOR AGENT Tissue decellularization
7322932, Mar 21 2002 Providence Health System - Oregon Method for suturelessly attaching a biomaterial to an implantable bioprosthesis frame
7329278, Nov 17 1999 Medtronic Corevalve LLC Prosthetic valve for transluminal delivery
7381218, Apr 06 2000 Edwards Lifesciences Corporation System and method for implanting a two-part prosthetic heart valve
7393360, Oct 11 2001 Edwards Lifesciences PVT, Inc. Implantable prosthetic valve
7399315, Mar 18 2003 Edwards Lifescience Corporation; Edwards Lifesciences Corporation Minimally-invasive heart valve with cusp positioners
7452371, Jun 02 1999 Cook Medical Technologies LLC Implantable vascular device
7473275, Apr 06 2005 Edwards Lifesciences Corporation Stress absorbing flexible heart valve frame
7704222, Sep 10 1998 JENAVALVE TECHNOLOGY, INC ; JVT RESEARCH & DEVELOPMENT CORPORATION Methods and conduits for flowing blood from a heart chamber to a blood vessel
7736327, Sep 10 1998 JENAVALVE TECHNOLOGY, INC ; JVT RESEARCH & DEVELOPMENT CORPORATION Methods and conduits for flowing blood from a heart chamber to a blood vessel
20010011187,
20010021872,
20010039450,
20020032481,
20020055775,
20020111668,
20020123790,
20020133226,
20020198594,
20030027332,
20030036791,
20030036795,
20030040792,
20030050694,
20030055495,
20030065386,
20030114913,
20030125795,
20030130726,
20030139796,
20030139803,
20030149476,
20030153974,
20030195620,
20030236570,
20040006380,
20040039436,
20040049262,
20040073289,
20040078950,
20040117004,
20040117009,
20040148018,
20040153145,
20040186558,
20040186563,
20040186565,
20040193244,
20040210301,
20040210304,
20040260389,
20050009000,
20050033220,
20050033398,
20050043790,
20050049692,
20050075725,
20050075776,
20050096726,
20050096736,
20050098547,
20050113910,
20050119728,
20050119736,
20050137687,
20050137688,
20050137690,
20050137697,
20050137698,
20050137702,
20050143804,
20050143807,
20050149166,
20050150775,
20050171597,
20050171598,
20050192665,
20050197695,
20050222668,
20050234546,
20050267560,
20060009842,
20060025857,
20060047343,
20060058864,
20060074484,
20060111770,
20060142846,
20060149360,
20060167543,
20060193885,
20060210597,
20060229718,
20060229719,
20060246584,
20060259134,
20060259136,
20060265056,
20060287717,
20060287719,
20060290027,
20060293745,
20070005129,
20070005131,
20070005132,
20070020248,
20070021826,
20070027535,
20070038291,
20070038295,
20070043435,
20070050014,
20070088431,
20070093887,
20070100435,
20070100440,
20070112422,
20070123700,
20070123979,
20070142906,
20070162103,
20070173932,
20070179592,
20070185565,
20070203576,
20070213813,
20070239271,
20070244551,
20070260327,
20070288087,
20080004688,
20080021546,
20080033534,
20080065011,
20080071361,
20080071362,
20080071363,
20080071366,
20080071368,
20080071369,
20080077236,
20080086205,
20080097586,
20080102439,
20080133003,
20080140189,
20080154355,
20080200977,
20080215143,
20080262602,
20080269878,
20080275549,
DE10010073,
DE10010074,
DE10121210,
DE19546692,
DE19633901,
DE19857887,
DE20003874,
EP84395,
EP402036,
EP402176,
EP458877,
EP515324,
EP547135,
EP592410,
EP729364,
EP756498,
EP778775,
EP786970,
EP871414,
EP888142,
EP928615,
EP971649,
EP986348,
EP987998,
EP1017868,
EP1041942,
EP1041943,
EP1051204,
EP1087727,
EP1089676,
EP1112042,
EP1117446,
EP1158937,
EP1164976,
EP1171061,
EP1206179,
EP1233731,
EP1235537,
EP1248655,
EP1251803,
EP1251804,
EP1251805,
EP1253875,
EP1255510,
EP1257305,
EP1259193,
EP1259195,
EP1281357,
EP1330213,
EP1347785,
EP1354569,
EP1395208,
EP1401359,
EP1406561,
EP1408882,
EP1414295,
EP1435878,
EP1435879,
EP1441672,
EP1452153,
EP1494616,
EP1499366,
EP1519697,
EP1539047,
EP1551274,
EP1560542,
EP1603493,
EP1663070,
EP1667614,
EP1702247,
EP1734902,
EP1835948,
EP1863545,
EP1878407,
EP1886649,
EP1893132,
EP1900343,
EP1901681,
EP1994913,
EP2000115,
GB2440809,
JP2002525169,
JP2002536115,
JP2003523262,
JP2003524504,
JP2005118585,
JP2007296375,
JP52086296,
JP62227352,
RE30912, Jun 14 1978 MEDTRONIC, INC , 7000 CENTRAL AVENUE, N E , MINNEAPOLIS, MINNESOTA 55432, A MN CORP Stent for heart valve
WO47139,
WO15148,
WO18333,
WO18445,
WO25702,
WO47139,
WO53125,
WO62714,
WO110209,
WO135870,
WO141679,
WO151104,
WO154625,
WO158503,
WO162189,
WO164137,
WO2058745,
WO2100301,
WO2102286,
WO236048,
WO3003949,
WO3007795,
WO3009785,
WO3011195,
WO3013239,
WO3028592,
WO3047468,
WO3079928,
WO3096935,
WO2004004597,
WO2004016200,
WO2004016201,
WO2004019825,
WO2004026117,
WO2004026173,
WO2004043301,
WO2004082527,
WO2004096100,
WO2005021063,
WO2005034812,
WO2005062980,
WO2005063980,
WO2005072654,
WO2006066327,
WO2006076890,
WO2006102063,
WO2006108090,
WO2006124649,
WO2006127756,
WO2006127765,
WO2006132948,
WO2007047488,
WO2007047945,
WO2007059252,
WO2007071436,
WO2007120543,
WO2008028569,
WO2008045949,
WO2008070797,
WO2008079962,
WO2008101083,
WO9009102,
WO9117720,
WO9524873,
WO9528183,
WO9613227,
WO9732615,
WO9843556,
WO9846165,
WO9937337,
WO9966863,
////////////
Executed onAssignorAssigneeConveyanceFrameReelDoc
Aug 21 2002DAMM, CHRISTOPHFRAUNHOFER-GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG E V ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0674930146 pdf
Aug 21 2002PESCHEL, THOMASFRAUNHOFER-GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG E V ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0674930146 pdf
Aug 22 2002WEBER, CARSTENFRAUNHOFER-GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG E V ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0674930146 pdf
Aug 22 2002FERRARI, MARKUSFRAUNHOFER-GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG E V ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0674930146 pdf
Aug 22 2002FIGULLA, HANS-REINERFRAUNHOFER-GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG E V ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0674930146 pdf
Jun 26 2008JenaValve Technology GmbH(assignment on the face of the patent)
May 27 2014JENAVALVE TECHNOLOGY, INC JenaValve Technology GmbHASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0330840369 pdf
Mar 10 2016JenaValve Technology GmbHJVT RESEARCH & DEVELOPMENT CORPORATIONASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0382790820 pdf
Mar 10 2016JVT RESEARCH & DEVELOPMENT CORPORATIONJENAVALVE TECHNOLOGY, INC ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0382760168 pdf
Nov 30 2018JENAVALVE TECHNOLOGY, INC KREOS CAPITAL V UK LIMITEDSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0483250368 pdf
Dec 29 2021JENAVALVE TECHNOLOGY, INC INNOVATUS LIFE SCIENCES LENDING FUND I, LPINTELLECTUAL PROPERTY SECURITY AGREEMENT0588940788 pdf
Jan 14 2022KREOS CAPITAL V UK LIMITEDJENAVALVE TECHNOLOGY, INC RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS 0588020452 pdf
Date Maintenance Fee Events
Oct 07 2014M1552: Payment of Maintenance Fee, 8th Year, Large Entity.
Oct 07 2014M1555: 7.5 yr surcharge - late pmt w/in 6 mo, Large Entity.
Nov 12 2014ASPN: Payor Number Assigned.
Dec 14 2015LTOS: Pat Holder Claims Small Entity Status.
Sep 25 2018M2553: Payment of Maintenance Fee, 12th Yr, Small Entity.


Date Maintenance Schedule
Sep 09 20174 years fee payment window open
Mar 09 20186 months grace period start (w surcharge)
Sep 09 2018patent expiry (for year 4)
Sep 09 20202 years to revive unintentionally abandoned end. (for year 4)
Sep 09 20218 years fee payment window open
Mar 09 20226 months grace period start (w surcharge)
Sep 09 2022patent expiry (for year 8)
Sep 09 20242 years to revive unintentionally abandoned end. (for year 8)
Sep 09 202512 years fee payment window open
Mar 09 20266 months grace period start (w surcharge)
Sep 09 2026patent expiry (for year 12)
Sep 09 20282 years to revive unintentionally abandoned end. (for year 12)